These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18584553)

  • 1. Severe acute polyarthritis in a child after high doses of moxifloxacin.
    Torres JR; Bajares A
    Scand J Infect Dis; 2008; 40(6-7):582-4. PubMed ID: 18584553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin--a new fluoroquinolone antibacterial.
    Drug Ther Bull; 2004 Aug; 42(8):61-2. PubMed ID: 15310155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxifloxacin-associated neutropenia.
    Berk V; Demiraslan H; Berk E; Karaca H; Inanc M; Bozkurt O; Ozkan M
    Scand J Infect Dis; 2013 May; 45(5):415-6. PubMed ID: 23151058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous moxifloxacin. Even more harmful than the oral form.
    Prescrire Int; 2011 Jun; 20(117):151. PubMed ID: 21678703
    [No Abstract]   [Full Text] [Related]  

  • 5. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
    Kovacic D; Fox M; Reichenberg J
    J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Moxifloxacin (Kanavig), ophthalmic administration].
    J Pharm Belg; 2012 Jun; (2):41-2. PubMed ID: 22978015
    [No Abstract]   [Full Text] [Related]  

  • 7. Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
    Prescrire Int; 2009 Oct; 18(103):207. PubMed ID: 19882788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with moxifloxacin in patients with respiratory tract infections.
    Faich GA; Morganroth J; Whitehouse AB; Brar JS; Arcuri P; Kowalsky SF; Haverstock DC; Celesk RA; Church DA
    Ann Pharmacother; 2004 May; 38(5):749-54. PubMed ID: 15026565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
    Lipsky BA; Giordano P; Choudhri S; Song J
    J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin-induced delirium with hallucinations.
    Tasleem H; Viswanathan R
    Psychosomatics; 2011; 52(5):472-4. PubMed ID: 21907069
    [No Abstract]   [Full Text] [Related]  

  • 12. Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.
    Chang B; Knowles SR; Weber E
    Ann Pharmacother; 2010 Apr; 44(4):740-5. PubMed ID: 20233910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Moxifloxacin and hepatic toxicity].
    Franco Hidalgo S; Prieto de Paula JM; García Lorenzo R; Salado Valdivieso I
    Gastroenterol Hepatol; 2009 Dec; 32(10):719-20. PubMed ID: 19664854
    [No Abstract]   [Full Text] [Related]  

  • 14. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gigantic study planned. 100,000 patients with COPD test general practice antibiotic].
    MMW Fortschr Med; 2004 Mar; 146(10):41. PubMed ID: 15347081
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in China.
    Liu LY; Landen H
    Int J Clin Pract; 2007 Sep; 61(9):1509-15. PubMed ID: 17635617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.
    Solomkin J; Zhao YP; Ma EL; Chen MJ; Hampel B;
    Int J Antimicrob Agents; 2009 Nov; 34(5):439-45. PubMed ID: 19692210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.
    Nori S; Nebesio C; Brashear R; Travers JB
    Arch Dermatol; 2004 Dec; 140(12):1537-8. PubMed ID: 15611441
    [No Abstract]   [Full Text] [Related]  

  • 19. A diagnostic dilemma: drug-induced aseptic meningitis in a 45-year-old HIV-positive man.
    Rowley D; Houlihan L; McFaul K; Clarke S; Lyons F
    Int J STD AIDS; 2014 Mar; 25(4):309-11. PubMed ID: 23999938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
    Chang CM; Lee NY; Lee HC; Lee IW; Wu CJ; Lin YS; Ko WC
    Ann Pharmacother; 2008 Apr; 42(4):580-3. PubMed ID: 18349304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.